PMID: 3889219Mar 1, 1985

An enzymatic assay for monitoring serum, cerebrospinal fluid, and urine concentration of beta-lactam antibiotics

Journal of Clinical Chemistry and Clinical Biochemistry. Zeitschrift Für Klinische Chemie Und Klinische Biochemie
W CullmannM Edelmann

Abstract

August 29/October 24, 1984 An enzymatic assay for the determination of the concentrations of various beta-lactam antibiotics in serum, urine, and cerebrospinal fluid samples is described. Recently developed beta-lactam derivatives are used as competitive inhibitors of the breakdown of the labile coloured beta-lactam compound PADAC, which serves as the substrate for the various beta-lactamases. Under the conditions of the assay, there is effectively no interference due to the matrix. Moreover, the assay is not influenced by other antibiotics such as aminoglycosides, macrolides, ansamycines, tetracyclines, fusidic acid or fosfomycin. The C.V.s for within-run precision ranged from 3.7% to 4.4%, depending on the beta-lactam derivative. The sensitivity of the assay is at least comparable with that of conventional procedures. Excellent correlations were observed between the enzymatic and the microbiological procedures; correlation coefficients: r = 0.988 for 22 imipenem samples, r = 0.968 for 16 cefotaxime samples, and r = 0.989 for 16 piperacillin samples routinely sent to our laboratory.

References

May 1, 1978·Clinical Pharmacokinetics·M Barza, M Lauermann

Citations

Feb 24, 2001·Spectrochimica Acta. Part A, Molecular and Biomolecular Spectroscopy·B TangH Y Wang

Related Concepts

pyridine-2-azo-4-dimethylaniline cephalosporin
Antibiotics
Beta-Lactamase
Cephalosporanic Acids
Alkalescens-Dispar Group

Related Feeds

CSF & Lymphatic System

This feed focuses on Cerebral Spinal Fluid (CSF) and the lymphatic system. Discover the latest papers using imaging techniques to track CSF outflow into the lymphatic system in animal models.

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Carbapenems (ASM)

Carbapenems are members of the beta lactam class of antibiotics and are used for the treatment of severe or high-risk bacterial infections. Discover the latest research on carbapenems here.

Carbapenems

Carbapenems are members of the beta lactam class of antibiotics and are used for the treatment of severe or high-risk bacterial infections. Discover the latest research on carbapenems here.